However, HIF1α expression is lost in 30–40% of overt ccRCCs, since HIF1α acts as a tumor suppressor during further progression of ccRCC by attenuating autonomous VHL-deficient tumor cell proliferation (Figure 1). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.